Peptide data sheet
GLOW Stack
Skincare · GLOW · GLOW blend
Verdict
unprovenThe unproven label is about the stack, not a dismissal of every part. GHK-Cu topical has real cosmetic data; the recovery peptides in the blend lean heavily on animal work. What is genuinely unproven is the combination — no study has tested these three together for the skin-and-recovery outcomes the bundle is sold on.
Quick answer
The GLOW stack is a blended vial of three research peptides — GHK-Cu, BPC-157 and TB-500 — commonly researched for skin appearance and tissue recovery. The important honest note is that these are studied individually, mostly in early or animal research; no controlled study has tested the three as a combined stack, and it is not FDA-approved.
- Class
- Multi-peptide blend (GHK-Cu copper tripeptide + BPC-157 + TB-500 fragment)
- Half-life
- not characterized for the blend (the individual peptides differ)
- FDA status
- Not FDA-approved. Sold for laboratory research use only; the blend and its individual peptides are research-grade materials, not approved drugs.
- WADA banned?
- Yes
Which form actually works?
Topical (as a GHK-Cu-led serum)
Promising
The copper-peptide part of this idea is where the real cosmetic evidence lives. Applied to skin, GHK-Cu has been studied in humans for appearance-related measures, which is why the topical route is the most defensible piece of the whole GLOW concept.
Injectable blend (the vial as sold)
Unproven
The vial that gets marketed as a stack. The recovery peptides in it are mostly backed by animal research, and the three-way combination has never been tested together in people. Convenient packaging is not the same as combined evidence.